Corcept Therapeutics | CORT - Trade Debtors


Corcept Therapeutics reported $69.63M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
ANI Pharmaceuticals USD 252.62M 26.96M Sep/2025
Ardelyx USD 76.61M 14.06M Sep/2025
Aurora Cannabis CAD 46.73M 7.59M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Canopy Growth CAD 26.86M 23.17M Sep/2025
Corcept Therapeutics USD 69.63M 5.06M Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
J&J USD 17.61B 235M Sep/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Merck USD 12.12B 596M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Pacira USD 115.27M 901K Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Supernus Pharmaceuticals USD 171.25M 30.42M Sep/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025